Vitamin D3

Generic Name: Vitamin D3

Brand Names: Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₄O

CAS Number: 67-97-0

Unique Ingredient Identifier: 1C6V77QF41

Background: Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalcifero...

Indication: Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .
...

Associated Conditions: Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture

Associated Therapies: Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Clinical Trials

Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI)

Phase 4

Conditions: Acute Coronary Syndrome
Cytokines

Interventions: Drug: Vitamin D

First Posted Date: 2010-05-04

Last Posted Date: 2010-08-20

Lead Sponsor: Meir Medical Center

Target Recruit Count: 50

Registration Number: NCT01115842

Locations: 🇮🇱
Meir Medical Center, Kfar-Sava, Israel

Vitamin D in Pregnancy and Lactation

Phase 4

Completed

Conditions: Vitamin D Deficiency

Interventions: Drug: Vitamin D
Drug: Vitamin D3

First Posted Date: 2010-04-29

Last Posted Date: 2014-12-16

Lead Sponsor: University of British Columbia

Target Recruit Count: 225

Registration Number: NCT01112891

Locations: 🇨🇦
BC Children's Hospital, Vancouver, British Columbia, Canada

Vitamin D Plus Fluticasone Propionate

Phase 4

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Placebo
Drug: Vitamin D3
Drug: Fluticasone Propionate

First Posted Date: 2010-04-15

Last Posted Date: 2014-10-09

Lead Sponsor: University of Chicago

Target Recruit Count: 35

Registration Number: NCT01103934

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients

Phase 4

Conditions: Kidney Diseases
Coronary Artery Calcification

Interventions: Drug: Vitamin K2+10μg cholecalciferol
Drug: Vitamin D

First Posted Date: 2010-04-12

Last Posted Date: 2010-04-13

Lead Sponsor: Medical University of Lodz

Target Recruit Count: 60

Registration Number: NCT01101698

Locations: 🇵🇱
Department of Nephrology, Hypertension and Kidney Transplantation, Łódź, Poland

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

Phase 2

Completed

Conditions: Human Immunodeficiency Virus (HIV)
HIV Infections
Vitamin D Deficiency

Interventions: Other: Placebo
Drug: Vitamin D

First Posted Date: 2010-03-25

Last Posted Date: 2016-07-14

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 45

Registration Number: NCT01093417

Locations: 🇺🇸
University Hospitals of Cleveland Case Medical Center, Cleveland, Ohio, United States

Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure

Phase 2

Completed

Conditions: Chronic Heart Failure

Interventions: Drug: Vitamin D

First Posted Date: 2010-03-24

Last Posted Date: 2013-02-15

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 101

Registration Number: NCT01092130

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

A Trial to Study the Effect of Long Term Vitamin D Supplementation on Insulin Sensitivity

Phase 4

Completed

Conditions: Insulin Resistance
Obesity

Interventions: Drug: placebo
Drug: Cholecalciferol

First Posted Date: 2010-01-20

Last Posted Date: 2019-09-04

Lead Sponsor: Dr Jitender Nagpal

Target Recruit Count: 300

Registration Number: NCT01052181

Locations: 🇮🇳
Sitaram Bhartia Institute of Science and Research, New Delhi, Delhi, India

Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease

Phase 1

Terminated

Conditions: Crohn's Disease
Vitamin D Deficiency

Interventions: Drug: Cholecalciferol

First Posted Date: 2010-01-12

Last Posted Date: 2018-02-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 3

Registration Number: NCT01046773

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Effects of Vitamin D Supplementation in Obesity

Phase 4

Completed

Conditions: Vitamin D Deficiency
Obesity

Interventions: Drug: Cholecalciferol
Drug: placebo

First Posted Date: 2009-12-21

Last Posted Date: 2012-08-02

Lead Sponsor: University of Aarhus

Target Recruit Count: 55

Registration Number: NCT01037140

Locations: 🇩🇰
Dept. of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark

Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements

Phase 3

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Vitamin D

First Posted Date: 2009-12-10

Last Posted Date: 2017-04-17

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 75

Registration Number: NCT01029392

Locations: 🇺🇸
WilliamBH, Royal Oak, Michigan, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy